Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: AZTR )

0.4720 +0.0020 (+0.43%)
Official Closing Price Updated: 4:10 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 128,819
Open 0.4653
Bid (Size) 0.4580 (40)
Ask (Size) 0.4740 (1)
Prev. Close 0.4700
Today's Range 0.4500 - 0.4824
52wk Range 0.4264 - 68.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Azitra to Present at BIO-Europe 2024
From Azitra, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
-98.50%
-98.50%
1 Month
-20.67%
-20.67%
3 Month
-36.90%
-36.90%
6 Month
-92.22%
-92.22%
1 Year
-98.82%
-98.82%

More News

Read More
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
From Azitra, Inc.
Via Business Wire
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
Via Benzinga
AZTR Stock Earnings: Anitra Reported Results for Q2 2024
Via InvestorPlace
Why Azitra Stock Is Crashing
Via Benzinga
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
From Azitra, Inc.
Via Business Wire
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
From Azitra, Inc.
Via Business Wire
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Azitra, Inc.
Via Business Wire
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
From Azitra, Inc.
Via Business Wire
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
From Azitra, Inc.
Via Business Wire
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
From Azitra, Inc.
Via Business Wire
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates
From Azitra, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering
From Azitra, Inc.
Via Business Wire
Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings
Via Benzinga
Exposures Fossil Fuels
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Tumbles 300 Points; Tesla Shares Plunge After Q2 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings
Via Benzinga
Why Is Conn’s (CONN) Stock Down 36% Today?
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
Why Is Azitra (AZTR) Stock Down 75% Today?
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering
From Azitra, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.